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Abstract
Background:  Liver  biopsy  is  the  main  diagnostic  tool  for  the  study  of  the  liver,  and  as  such,  its
inherent complications  have  been  minimised  as  much  as  possible  over  the  years,  through  the
modiﬁcation  of  several  factors  regarding  its  procedure,  including  post-biopsy  recovery  time.
The aim  of  this  study  was  to  evaluate  the  safety  in  the  reduction  of  post-liver  biopsy  recovery
time.
Material and  methods:  A  non-blinded,  randomised  clinical  trial  was  conducted  in  the
‘‘Hermanos  Ameijeiras’’  Hospital  from  November  2011  to  October  2012,  on  128  patients  in  order
to assess  safety  when  reducing  post-biopsy  recovery  times.  The  patients  were  randomised  into
2 groups.  Group  A  was  allowed  a  6-h  recovery  time,  while  Group  B  was  allowed  a  2-h  recovery
time after  liver  biopsy.  Complications  were  fully  recorded.  The  Chi  squared  test  of  homogeneity
and Student  t  test  was  used  as  appropriate,  in  the  statistical  analysis,  a  signiﬁcance  level  of
0.05 was  set.
Results:  The  main  biopsy  indication  was  elevated  plasma  transaminases.  Pain  in  the  puncture
site was  the  most  recurrent  complication  (67.2%),  and  the  most  serious  complication  was  sub-
capsular  liver  haematoma  in  two  cases  (1.6%).  There  were  no  differences  regarding  the  liver
biopsy technique  that  could  have  caused  complications  in  any  group.
Conclusions:  There  were  no  signiﬁcant  differences  between  2  h  and  6  h  post-liver  biopsy  recov-
ery time  in  terms  of  complications,  so  it  is  considered  that  after  2  h  the  patient  is  incorporated
more quickly  into  their  activities,  and  the  institution  spends  less  material  and  human  resources.
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Seguridad  de  la  reducción  del  tiempo  de  reposo  posbiopsia  hepática  percutánea  y  por
vía  laparoscópica
Resumen
Antecedentes:  La  biopsia  hepática  es  una  herramienta  diagnóstica  para  el  estudio  del  hígado,
por lo  que  en  su  evolución  se  han  tratado  de  minimizar  las  complicaciones  mediante  la  modiﬁ-
cación de  varios  factores  en  relación  con  su  realización,  incluido  el  tiempo  de  reposo  posbiopsia.
El objetivo  de  esta  investigación  fue  evaluar  la  seguridad  de  la  reducción  del  tiempo  de  reposo
posbiopsia  hepática.
Material  y  métodos: Se  realizó  un  ensayo  clínico,  aleatorizado,  sin  cegamiento,  en  el  Hospital
Clínico Quirúrgico  «Hermanos  Ameijeiras»,  en  el  período  comprendido  entre  noviembre  de  2011
y octubre  de  2012.  Se  eligieron  128  pacientes  que  fueron  asignados  aleatoriamente  a  2  grupos:
grupo A  con  reposo  de  6  h  y  grupo  B  con  2  h  de  reposo  posbiopsia  hepática.  Se  registraron  las
complicaciones.  En  el  análisis  estadístico  se  utilizó  la  prueba  de  chi  cuadrado  de  homogeneidad
y la  t  de  Student  según  correspondiera;  se  ﬁjó  un  nivel  de  valour  estadístico  signiﬁcativo  de
0.05.
Resultados:  El  dolor  en  el  sitio  de  punción  resultó  la  complicación  más  frecuente  (67.2%)  y  la
más grave  fue  el  haematoma  hepático  subcapsular  con  2  casos  (1.6%),  sin  diferencias  con  la
técnica empleada  en  la  biopsia  para  la  aparición  de  complicaciones  en  ambos  grupos.
Conclusiones:  No  existieron  diferencias  signiﬁcativas  entre  el  tiempo  de  reposo  posbiopsia  hep-
ática de  2  h  y  el  de  6  en  cuanto  a  complicaciones,  por  lo  que  se  considera  que  con  el  de  2  h  el
paciente  se  incorpora  más  rápidamente  a  sus  actividades  y  la  institución  dedica  menos  recursos
materiales  y  humanos.
© 2016  Publicado  por  Masson  Doyma  Me´xico  S.A.  a  nombre  de  Academia  Mexicana  de  Cirug´ıa
A.C. Este  es  un  art´ıculo  Open  Access  bajo  la  CC  BY-NC-ND  licencia  (http://creativecommons.
org/licencias/by-nc-nd/4.0/).
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iBackground
Anatomopathological  study  of  the  liver  has  formed  the
basis  of  hepatology,  and  liver  biopsy  its  principal  tool,
because  it  enables  in  vivo  exploration  and  can  be  repeated
sequentially.1 Percutaneous  liver  biopsy  is  a  procedure  which
is  used  worldwide,  both  because  of  its  safety  and  because
it  is  highly  useful  in  evaluating  and  managing  patients
with  liver  disease.  Despite  the  fact  that  liver  biopsy  was
used  for  the  ﬁrst  time  in  Germany  by  Ehrlich  in  1883,  it
was  only  after  1958  when  Menghini,2 with  his  so-called
‘‘one-second  biopsy’’  technique,  managed  to  ensure  the
widespread  use  of  this  procedure.  Liver  biopsy  started  to
be  used  increasingly  from  1970  onwards  due  to  the  develop-
ment  and  evolution  of  cytopathological  techniques,  due  to
the  technical  advances  in  imaging  studies  enabling  effective
and  minimally  invasive  access  to  perform  the  procedure,  and
due  to  the  advances  in  puncture  needle  technology;  all  of
which  have  made  this  procedure  really  safe.3
At  present,  it  is  considered  that  liver  biopsy  is  indicated
in  order  to:  (a)  determine  the  cause  of  alterations  in  liver
function  tests,  of  no  precise  cause;  (b)  evaluate  alcoholic
liver  disease  and  non-alcoholic  liver  disease;  (c)  investigate
fever  of  unknown  origin;  (d)  establish  a  diagnosis  of  multisys-
temic  granulomatous  and  inﬁltrating  disease;  (e)  conﬁrm  the
aetiology  of  intrahepatic  cholestasic  disease;  (f)  support  a
diagnosis  and  to  stage  primary  and  secondary  cancers  in  the
liver,  which  also  enables  us  to  perform  the  relevant  immuno-
histochemical  study;  (g)  assess  the  extent  of  drug-induced
liver  damage;  (h)  achieve  a  diagnosis  for  hidden  causes  of
hepatomegaly,  jaundice  and  hereditary  metabolic  diseases
e
w
of  the  liver;  (i)  establish  a  diagnosis  in  relation  to  the  degree
f  activity  and  staging  of  chronic  hepatitis  and  response
o  treatment;  (j)  follow-up  and  evaluate  complications  in
ransplanted  patients;  and  (k)  determine  the  cause  of  acute
iver  failure.4--11
As  with  any  medical  procedure  which  carries  a  risk,
here  are  contraindications.  These  contraindications  can
e  divided  into  absolute  (failure  to  cooperate  on  the
art  of  the  patient,  severe  coagulopathy,  infection  of  the
iver  bed  and  marked  extrahepatic  biliary  obstruction)  and
elative  (ascites,  morbid  obesity,  vascular  lesions,  amyloid-
sis,  hydatid  disease).12--14 The  available  techniques  are
ltrasound-guided  blind  percutaneous  biopsy,  transjugular
iopsy  and  the  laparoscopic  approach.7--15
Minor  complications  can  occur  in  liver  biopsy  (30%),  such
s  localised  and  temporary  discomfort  at  the  site  of  the
iopsy,  pain  that  requires  analgesia  and  low  blood  pressure
ue  to  a vasovagal  response.  Major  complications  can  also
rise  (0.3%),  including  intraperitoneal  haemorrhage,  intra-
epatic  or  subcapsular  haematoma  and  biliary  peritonitis,
hich  can  even  be  fatal  (0.03%).5--16 Different  studies  have
hown  that  61%  of  complications  occur  in  the  ﬁrst  2  h  after
he  biopsy  and  96%  within  the  ﬁrst  24  h.16--21
Care  after  a liver  biopsy  has  varied  considerably  over  the
ears,  especially  with  regard  to  rest  time.  Hospitalisation  for
he  24  h  following  the  procedure  was  indicated  more  than  20
ears  ago,  during  which  time  the  patient  was  required  to  lie
n  the  right  lateral  position  or  prone  for  6  h  and  then  lie  on
ither  side  for  the  remainder  of  the  time.22 This  rest  time
as  later  reduced  to  6  h  in  our  centre  --  from  the  start  of
ur  department  in  1983  --  and  as  either  an  outpatient  or
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npatient,  with  no  serious  complications  of  mortality
eported  at  all.  In  1996  a  study  was  performed  in  the
ational  Gastroenterology  Institute  called  ‘‘early  mobilisa-
ion’’  after  4  h  rest,  but  with  strict  clinical  monitoring  for
4  h.23
In  recent  years,  studies  have  been  published  which  argue
hat  one  hour’s  rest  post  biopsy  under  strict  clinical  monitor-
ng  is  just  as  safe  as  rest  for  longer  periods  of  time.24,25 These
tudies  demonstrate  that  complications  present  in  the  ﬁrst
ours  post  biopsy,  which  was  our  motivation  for  undertak-
ng  this  study  where  we  propose  shortening  the  post-biopsy
est  time  to  only  2  h,  lying  in  the  right  lateral  position,
or  the  percutaneous  technique  after  ultrasound  marking  or
rone  after  laparoscopic-guided  biopsy,  under  strict  medical
upervision  which  would  result  in  the  patient  being  able  to
esume  their  routines  early,  and  reduce  hospital  costs.
aterial and methods
 non-blinded,  randomised  clinical  trial  was  carried  out  in
he  Gastroenterology  Department  of  the  ‘‘Hermanos  Amei-
eiras’’  Hospital  between  1  November  2011  and  31  October
012  including:  all  the  patients  who  required  a  liver  biopsy,
s  either  inpatients  or  outpatients,  whatever  the  cause,
f  either  gender  and  over  the  age  of  18.  Patients  who
resented  blood  dyscrasia  or  any  other  disease  affecting
oagulation  and  predisposing  them  to  haemorrhage,  with
aemoglobin  levels  below  8  g/dl,  thrombocytopenia  of  less
han  70,000  platelets  or  a  prothrombin  deﬁciency  with  lev-
ls  below  50%;  or  with  vascular  or  cystic  tumours  of  the  liver
ere  excluded  from  the  study.  Therefore,  the  sample  com-
rised  128  patients,  who  were  randomised  into  2  groups:
roup  A  and  group  B;  the  doctor  was  informed  during  the
urgical  procedure  itself.  The  random  allocation  was  per-
ormed  by  a  specialist  in  biostatistics,  concealed  in  opaque
nvelopes  with  the  patients’  number  on  the  outside  and  the
tudy  group  inside.  These  were  kept  in  the  Gastroenterology
epartment  in  the  care  of  the  Charge  Nurse.  After  their  liver
iopsy,  the  patients  in  group  A  were  told  to  rest  in  the  right
ateral  position  if  they  had  had  a  percutaneous  biopsy,  and
o  lie  prone  if  they  had  had  a  laparoscopic  biopsy,  for  2  h,
nd  then  to  lie  on  either  side  for  4  more  hours.  The  patients
n  group  B  were  told  to  rest  for  2  h  only,  in  the  same  way.
oth  groups  were  strictly  monitored  and  their  blood  pres-
ure  and  heart  rate  taken  every  15  min  for  the  ﬁrst  hour,
hen  every  30  min  for  the  second  hour  and  every  hour  for
he  4  remaining  hours  for  the  patients  in  group  A.  The  out-
atients  were  discharged  after  the  rest  time,  regardless  of
heir  study  group,  as  long  as  they  had  not  presented  any
ajor  complication,  and  we  contacted  them  by  telephone
n  the  following  24  h  to  ﬁnd  out  how  they  were  progressing.
ll  complications  were  fully  recorded.
tatistical  analysis
ercentages  were  used  for  the  qualitative  variables  and  the
ean  with  standard  deviation  for  the  quantitative  variables.
he  Chi  squared  test  and  Fisher’s  exact  test  were  used  when
here  were  25%  or  more  expected  frequencies  less  than  5,  to
ompare  proportions  in  the  qualitative  variables.  The  means
ere  compared  using  the  Student  t-test;  a  level  of  0.05
c
a
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as  set  for  the  comparison  to  be  considered  statistically
igniﬁcant.
The  decision  to  include  patients  who  had  undergone  an
ltrasound-guided  percutaneous  biopsy  with  patients  who
ad  had  a  laparoscopic  biopsy  in  one  group  was  because  they
ad  all  had  liver  biopsies  with  a  Menghini  needle  and  the
onitoring  procedure  is  the  same.  The  difference  between
lind  percutaneous  biopsy  and  laparoscopic  biopsy  was  only
o  identify  the  most  appropriate  site  for  the  biopsy,  tak-
ng  into  account  the  size  of  the  liver  and  the  absence  of
ascular  malformations  and  cysts.  Ultrasound  was  used  in
he  percutaneous  biopsies  and  it  was  identiﬁed  visually  in
he  laparoscopic  biopsies,  therefore  there  was  no  difference
n  the  procedure  for  the  puncture,  or  therefore  in  possible
omplications  and  monitoring  times.  We  did  not  attempt  to
ompare  either  form  of  guidance  either.
The  type  of  liver  biopsy  to  be  undertaken,  percuta-
eous  or  laparoscopic,  was  randomly  distributed,  according
o  whether  or  not  there  was  a  need  for  the  attending
hysician  to  assess  the  liver  macroscopically.  In  order  to
erform  the  traditional  ‘‘blind’’  percutaneous  liver  biopsy,
rst  ultrasonic  marking  was  performed  to  avoid  puncturing
ny  vascular  malformations,  the  gallbladder  or  other  vis-
era.  Then,  with  the  patient  in  the  supine  position  with  their
ight  arm  under  their  head,  hepatic  dullness  was  checked
y  percussing  the  intercostal  space  marked  on  the  mid
xillary  line;  after  asepsis  and  antisepsis  of  the  area,  the
uncture  site  was  inﬁltrated  with  lidocaine  2%,  ﬁrst  the
pidermis  and  then  a  deeper  level,  then  a millimetre,  sur-
ace  incision  was  made  using  the  tip  of  a scalpel  to  allow
ntry  of  the  lancet,  which  was  used  to  open  a  passage
hrough  the  intercostal  space,  until  entering  the  abdominal
avity.  Finally,  after  checking  the  permeability  of  the  14-
auge  Menghini  needle  (2.1  mm  in  diameter),  by  expelling
 small  amount  of  physiological  saline  solution,  the  needle
as  introduced  until  it  came  into  contact  with  the  sur-
ace  of  the  liver,  where  a further  instillation  was  made,
n  order  to  expel  any  tissue  that  might  have  penetrated
nto  the  needle  as  it  was  being  introduced;  the  patient  was
nstructed  to  hold  their  breath  and  by  applying  intensive  suc-
ion  to  the  syringe,  the  Menghini  needle  was  introduced  and
emoved  immediately  to  obtain  the  sample  and  deposit  it
n  a vial  containing  10%  formalin,  for  anatomopathological
ssessment.
Liver  biopsy  under  laparoscopic  vision  was  started  by
erforming  a  laparoscopy  under  local  anaesthesia  without
edation,  in  order  to  then  introduce  the  Menghini  needle
hrough  a  surgical  laparoscope  to  obtain  a  sample  of  liver
issue  for  histological  study.
The  following  criteria  governed  the  liver  biopsies  per-
ormed  on  outpatients:  1.  They  had  to  be  able  to  return
o  the  hospital  within  at  least  30  min.  2.  They  had  to  be
ccompanied  by  a  family  member  or  friend  to  have  the  pro-
edure  performed  and  during  their  ﬁrst  night  at  h  ome.  3.
hey  must  not  present  any  associated  disease  which  would
ncrease  the  risk  of  complications.  4.  They  would  be  hos-
italised  if  more  than  one  dose  of  analgesia  was  required
ithin  the  ﬁrst  hours.
All  the  patients  in  both  groups  were  informed  of  the  spe-
iﬁc  objective  of  the  procedure  and  possible  complications,
nd  they  gave  their  consent  and  approval  according  to  the
rinciples  of  the  II  Helsinki  declaration.
Safety  of  reducing  the  recovery  time  after  percutaneous  and  lap
Table  1  Patient  characteristics  according  to  study  group.
Characteristics  Group  A
n =  61
Group  B
n  =  67
p
Mean  age  (years)  47.6  ±  15.1  49.7  ±  13.6  0.4101a
Age  groups  (years)
18--30  11  (18%)  5  (7.5%)  0.079b
31--50  21  (38.2%)  34  (61.8%)
51 and  more  29  (50.9%)  28  (49.1%)
Sex
Male  30  (49.2%) 26  (38.8%)  0.316c
Female  31  (50.8%) 41  (61.2%)
Hospital  condition
External  consultation  31  (50.8%)  44  (65.7%)  0.127c
Inpatient  30  (49.2%)  23  (34.3%)
Type  of  biopsy
Percutaneous  35  (57.4%)  50  (74.6%)  0.061c
Laparoscopic  26  (42.6%)  17  (25.4%)
Source: Data collection sheet.
a Student t-test.
b Chi squared test of homogeneity.
a
t
o
o
b
t
w
a
s
a
g
i
m
f
t
c
t
l
w
t
s
m
i
t
s
s
p
w
w
w
b
mc Chi squared test of homogeneity with correction for
continuity.
Results
Table  1  presents  the  characteristics  of  the  patients  dis-
tributed  in  both  study  groups,  it  was  observed  that  there
were  no  signiﬁcant  differences  (p  >  0.05)  between  them  in
terms  of  age,  sex,  hospital  condition  or  type  of  biopsy  per-
formed.
With  regard  to  the  indication  for  a  liver  biopsy  in  both
study  groups,  most  were  performed  on  patients  with  altered
hepatic  enzymes,  followed  by  hepatitis  C;  other  causes  were
much  less  frequent  (Table  2).
As  can  be  observed  in  Table  3,  minor  complications  arose
in  most  of  the  patients  in  both  study  groups  almost  equally,
r
(
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Table  2  Indication  for  biopsy  according  to  study  group.
Indication  Group  A  
n  %  
Altered  liver  enzymes  19  31.1  
CVH hepatitis  12  19.7  
Intrahepatic cholestasis  5  8.2  
Liver metastasis  5  8.2  
BVH hepatitis  por  5  8.2  
Fever of  unknown  origin  3  4.9  
Alcoholism 4  6.6  
Hepatomegaly  under  study  3  4.9  
Wilson’s disease  1  1.6  
Pain in  the  right  hypochondrium  1  1.6  
Other 3  4.9  
Total 61  100  
Source: Data collection sheet.
BVH: B virus hepatitis; CVH: C virus hepatitis.aroscopic  liver  biopsy  199
t  65.5%  for  group  A  and  68.7%  for  group  B,  giving  67.2%  for
he  total  number  of  patients  studied.  Major  complications
nly  occurred  in  group  A  with  2  cases  corresponding  to  3.3%
f  the  patients  in  this  group  and  to  1.6%  of  the  total  num-
er  of  patients  in  both  groups.  The  2  major  complications
hat  presented  were  2  cases  with  subcapsular  haematoma
hich  progressed  satisfactorily  with  conservative  treatment
nd  follow-up  with  imaging  studies  for  72  h.  There  were  no
igniﬁcant  differences  (p  >  0.05)  on  comparing  the  percent-
ge  of  major  and  minor  complications  between  the  2  study
roups.
With  regard  to  minor  complications,  it  was  seen  that  both
n  general  (48.4%)  and  per  study  group  (45.9%  vs.  50.7%),
ost  patients  had  pain  at  the  puncture  site;  next  in  order  of
requency  was  abdominal  pain  at  29.5%  and  23.8%  respec-
ively  for  groups  A  and  B.  Another  minor  but  less  frequent
omplication,  was  severe  shoulder  pain  which  required  more
han  one  dose  of  analgesia,  and  then  there  were  more  iso-
ated  cases  such  as  vasovagal  crisis  and  chest  pain,  there
as  only  once  case  of  the  latter  (Table  4).
On  comparing  the  presence  of  complications  according
o  the  biopsy  technique  used,  it  was  observed  that  the  biop-
ies  via  the  laparoscopic  route  had  slightly  more  minor  and
ajor  complications,  but  this  difference  was  not  signiﬁcant
n  either  situation  (p  >  0.05).
From  the  detail  of  the  minor  complications  presented  by
he  patients  who  underwent  percutaneous  biopsies  in  both
tudy  groups,  it  can  be  observed  that  pain  at  the  puncture
ite  is  still  the  most  frequent,  both  generally  (56.5%)  and
er  study  group  (54.2%  vs.  58%)  (Table  5).
The  most  frequent  minor  complication  in  the  patients
ho  underwent  laparoscopic  biopsy,  unlike  those  who  under-
ent  percutaneous  biopsy,  was  abdominal  pain  (44.2%),  this
as  similar  in  both  groups  (42.3%  vs.  47.1%).  The  large  num-
er  of  patients  with  shoulder  pain  is  striking  (11.6%),  which
ight  be  explained  by  the  effect  of  the  pneumoperitoneumequired  to  undertake  a  laparoscopic  procedure.
Of  the  total  number  of  patients  included  in  the  study,  34
26.6%)  required  2  punctures  to  obtain  liver  tissue,  and  of
hese  85.3%  had  minor  complications;  only  5  patients  (3.9%)
Group  B  Total
n  %  n  %
20  29.9  39  30.5
23  34.3  35  27.3
6  9  11  8.6
3  4.5  8  6.3
2  3  7  5.5
4  6  7  5.5
2  3  6  4.7
2  3  5  3.9
2  3  3  2.3
1  1.5  2  1.6
2  3  5  3.9
67  100  128  100
200  P.O.  Nodarse-Pérez  et  al.
Table  3  Distribution  of  patients  according  to  complications  and  study  group.
Complications  Group  A  Group  B  Total
n  %  n  %  n  %
With  minor  complications* 40  65.5  46  68.7  86  67.2
With major  complications** 2  3.3  0  0  2  1.6
With no  complications  19  31.2  21  31.3  40  31.2
Total 61  100  67  100  128  100
Source: Data collection sheet.
* Chi squared test with Yates correction = 0.008, p = 0.929.
** Fisher’s test p = 0.488.
Table  4  Patients  according  to  the  presence  of  minor  complications  and  study  groups.
Minor  complications  Group  A  (n  =  61)  Group  B  (n  =  67)  Total  (n  =  128)
n  %  n  %  n  %
Pain  at  puncture  site  28  45.9  34  50.7  62  48.4
Abdominal pain  18  29.5  16  23.8  34  26.6
Intense pain  3  4.9  4  5.9  10  7.8
Vasovagal crisis  2  3.3  2  3.0  4  3.1
Chest pain  1  1.6  0  0  1  0.8
Shoulder pain  3  4.9  3  4.5  6  4.7
Source: Data collection sheet.
Table  5  Patients  with  percutaneous  biopsy  according  to  minor  complications  and  study  group.
Minor  complications  Group  A  (n  =  35)  Group  B  (n  =  50)  Total  (n  =  85)
n  %  n  %  n  %
Pain  at  puncture  site  19  54.2  29  58  48  56.5
Abdominal pain  7  20  8  16  15  17.6
Intense pain  2  5.7  1  2  3  3.5
Vasovagal crisis 1  2.8  1  2  2  2.3
Chest pain  1  2.8  0  0  1  1.2
Shoulder pain 0  0  1  2  1  1.2
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Source: Data collection sheet.
equired  3  punctures,  presenting  minor  complications  in  all
ases.  The  patients  who  required  a  single  puncture  pre-
ented  the  fewest  complications  (58.4%).  It  is  striking  that
he  only  2  major  complications  occurred  in  the  patients  who
nderwent  2  punctures.
iscussion
iver  biopsy  has  made  it  possible  to  gain  better  knowledge
f  the  anatomopathological  basis  of  liver  disease,  its  evolu-
ion  and  response  to  treatment.  This  is  why  this  procedure
emains  in  constant  use  despite  the  risk  of  complications
nd  the  appearance  of  sophisticated  diagnostic  imaging
ethods,  in  an  attempt  to  substitute  the  procedure.  How-
ver,  over  time,  various  aspects  have  changed  in  terms  of
ts  use  per  se  and  principally  concerning  post-biopsy  care.
his  study  is  based  on  the  latter  and  with  the  latest  data
l
p
s
d16  32  28  32.9
vailable  from  the  global  scientiﬁc  environment  we  con-
ider  that  rest  after  a  liver  biopsy  should  not  exceed  2  h
n  selected  patients.
De  la  Barra  et  al.26 performed  a  retrospective  study  in
hile  in  2010,  where  23  patients  underwent  percutaneous
iver  biopsies  as  outpatients.  The  average  age  of  the  patients
tudied  was  53.2,  with  a  range  from  27  to  68.  Our  research
tudy  had  a  greater  number  of  patients  with  a  broader  age
ange  and  average  age  almost  5  years  younger,  similar  to  the
ata  on  age  published  by  Beddy  et  al.27 in  2007,  where  500
atients  were  studied  with  an  average  age  of  43  and  a  range
rom  18  to  76.
There  is  little  published  research  comparing  the  results
nd  complications  of  percutaneous  biopsy  with  those  of
aparoscopic  biopsy.  However,  there  is  evidence  of  a  study
erformed  by  Denzer  et  al.15 in  2007  which  compares  laparo-
copic  and  percutaneous  biopsies  in  diagnosing  cirrhosis;  to
o  this,  857  patients  were  randomised  into  2  groups,  one
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RSafety  of  reducing  the  recovery  time  after  percutaneous  an
group  underwent  percutaneous  biopsy  (415)  and  the  other
laparoscopic  biopsy  (442)  with  very  equal  ﬁgures  as  can  be
observed,  unlike  those  we  present  in  this  study,  where  the
percutaneous  technique  was  used  in  a  much  higher  num-
ber  of  patients.  This  is  because,  unlike  Denzer  et  al.15 we
did  not  allocate  the  biopsy  technique  randomly,  but  rather
according  to  whether  or  not  there  was  a  need  to  assess  the
liver  macroscopically  as  outlined  in  the  section  ‘‘Material
and  methods’’.
There  are  few  publications  which  compare  2  study  groups
according  to  post-liver  biopsy  complications  with  different
post-biopsy  rest  periods.  However,  there  is  one  very  impor-
tant  study  performed  by  Firpi  et  al.28 published  in  2005,
where  a  9-year  study  of  3214  patients  was  undertaken,
in  which  the  post-biopsy  rest  period  was  shortened  over
the  years  from  6  h  in  1995  to  1  h  in  2004,  recording  the
complications  that  occurred  in  the  different  post-biopsy  rest
periods.  The  percutaneous  biopsy  technique  was  used  and
the  minor  complications  which  occurred  in  general  in  this
study  included:  pain  at  the  puncture  site  (13%),  abdominal
pain  (18%)  and  vasovagal  crisis  (0.5%);  these  percentages  are
smaller  than  those  presented  by  the  patients  who  underwent
percutaneous  biopsies  in  our  study,  with  the  exception  of
that  of  abdominal  pain  which  is  a  similar  ﬁgure.  It  is  worth
highlighting  the  much  greater  number  of  patients  who  pre-
sented  pain  at  the  puncture  site  in  this  study  compared  to
Firpi  et  al.28 study,  although  it  coincides  with  another  study
performed  by  Eisemberg  et  al.29 published  in  2003,  which
reported  that  84%  of  patients  who  underwent  percutaneous
biopsy  experienced  this  pain.
The  percentage  of  major  complications  reported  by
Firpi  et  al.28 was  0.9%,  with  2  deaths  (0.06%),  this  ﬁg-
ure  is  slightly  lower  than  this  series  in  terms  of  major
complications  and  there  was  not  a  single  death.  On  compar-
ing  the  complications  occurring  in  the  different  post-biopsy
rest  periods,  Firpi  et  al.28 found  no  signiﬁcant  differences,
and  neither  did  we  in  this  study.  The  fact  that  these  stud-
ies  report  a  lower  percentage  of  complications  than  the
data  found  in  this  work  might  be  explained  by  the  follow-
ing:  ﬁrst, the  small  size  of  the  sample,  given  that  most
reports  are  based  on  large  caseloads;  second,  the  proce-
dure  being  carried  out  by  interns  in  training,  because  the
experience  of  the  surgeon  is  a  factor  in  the  appearance  of
complications,18,30 although  in  2004  Chevallier  et  al.31 pub-
lished  a  study  refuting  this  concept;  third, the  diameter
of  the  Menghini’s  needle  used  in  our  study  is  larger  than
that  of  the  needles  used  in  the  abovementioned  studies,
according  to  Sterling  et  al.32 and  Plecha33 et  al.,  this  fac-
tor  might  increase  the  amount  of  complications;  and  four,
most  of  the  biopsies  in  these  studies  were  guided  by  ultra-
sound  in  real  time  and  not  after  ultrasound  marking  as  in
our  study,  although,  according  to  a  study  published  in  2007
by  Manolakopoulos  et  al.34 this  factor  should  not  inﬂuence
complications.
In  order  to  compare  the  presence  of  complications
according  to  the  biopsy  technique  used,  we  again  cite  the
study  published  by  Denzer  et  al.15 which  observed  that  the
percentage  of  minor  complications  reported  in  the  percu-
taneous  biopsy  group  was  5.8%  of  the  patients,  pain  (1.7%)
and  vasovagal  crisis  (1.4%)  being  the  main  complications,
percentages  less  than  8.8%  presented  in  the  laparoscopy
group,  where  pain  also  came  ﬁrst  at  3.2%  followed  byaroscopic  liver  biopsy  201
gitation  and  restlessness,  and  other  at  2.7%;  however  these
ifferences  were  not  statistically  signiﬁcant.  The  percent-
ges  of  minor  complications  in  our  study  were  greater  both
ith  the  percutaneous  and  the  laparoscopic  techniques  than
hose  reported  by  Denzer  et  al.15 but,  like  that  study,  with  no
igniﬁcant  differences  between  either  study  group.  On  eval-
ating  the  major  complications,  Denzer  et  al.15 reported  1%
n  the  percutaneous  biopsy  group  (intra-abdominal  haemorr-
age  0.7%,  and  haemobilia  0.3%),  this  percentage  is  much
igher  than  that  found  in  the  laparoscopy  group  at  only  0.2%
n  one  case  of  haemobilia,  with  no  death  reported,  on  this
ccasion  a  signiﬁcant  difference  presented  between  both
tudy  groups  (p  =  0.025).  Although  these  percentages  are  still
ower  than  those  reported  in  our  study,  where  there  was  no
igniﬁcant  difference  between  the  patients  who  underwent
ercutaneous  biopsy  and  those  who  underwent  laparoscopic
iopsy  in  relation  to  major  complications,  they  reﬂect  the
pposite  to  that  found  in  Denzer  et  al.15 study,  which  jus-
iﬁed  integrating  both  groups  to  reassess  the  monitoring
rocedure.
With  regard  to  the  number  of  punctures  required,  Firpi
t  al.28 reported  that  20%  of  their  patients  required  2  punc-
ures  and  0.2%  required  3;  these  results  are  slightly  lower
han  those  found  in  our  study,  however,  like  Firpi  et  al.28
t  was  demonstrated  that  the  complications  were  more  fre-
uent  when  more  than  one  puncture  was  required.
As  established  in  the  previous  paragraphs,  this  research
tudy  has  certain  limitations,  but  the  authors  consider  that
he  main  limitations  are  the  few  current  publications  on  this
ubject  in  the  scientiﬁc  world  and  the  lack  of  standardisa-
ion  in  terms  of  reporting  complications  post  liver  biopsy,
specially  with  regard  to  pain,  as  there  is  no  international
onsensus  on  this  factor.  Therefore,  correlation  between
he  different  series  published  world-wide  is  difﬁcult,  if  not
mpossible.
onclusions
andomly  allocating  the  study  groups  ensured  their  homo-
eneity  in  terms  of  demographic  variables  and  hospital
ondition,  and  this  ensured  correct  comparison.  There  were
o  differences  between  the  2  study  groups  with  regard  to
he  presence  of  minor  and  major  complications,  and  there-
ore,  post-biopsy  care  of  2  h  is  feasible  as  a  better  option.
e  recommend  that  this  safe  reduction  in  post-liver  biopsy
are  should  be  generalised  to  all  secondary  and  tertiary  level
nstitutions.
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